Octant has developed a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells. By linking receptor activity to genetic barcodes in a pooled fashion, Octant can screen small-molecule libraries against comprehensive sets of drug targets. These large datasets enable them to develop and apply machine learning methods to engineer small molecules that interact with multiple receptors to treat complex diseases.
OCTOPUS is a method for full-plasmid sequence verification.
Octant moves office location to Emeryville